These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

306 related articles for article (PubMed ID: 24529196)

  • 21. Impact of renal function on the effects of LDL cholesterol lowering with statin-based regimens: a meta-analysis of individual participant data from 28 randomised trials.
    ; Herrington WG; Emberson J; Mihaylova B; Blackwell L; Reith C; Solbu MD; Mark PB; Fellström B; Jardine AG; Wanner C; Holdaas H; Fulcher J; Haynes R; Landray MJ; Keech A; Simes J; Collins R; Baigent C
    Lancet Diabetes Endocrinol; 2016 Oct; 4(10):829-39. PubMed ID: 27477773
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Lipid-lowering therapy in persons with chronic kidney disease: a systematic review and meta-analysis.
    Upadhyay A; Earley A; Lamont JL; Haynes S; Wanner C; Balk EM
    Ann Intern Med; 2012 Aug; 157(4):251-62. PubMed ID: 22910936
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The Effects of SGLT2 Inhibitors on Cardiovascular and Renal Outcomes in Diabetic Patients: A Systematic Review and Meta-Analysis.
    Lo KB; Gul F; Ram P; Kluger AY; Tecson KM; McCullough PA; Rangaswami J
    Cardiorenal Med; 2020; 10(1):1-10. PubMed ID: 31743918
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Effects of statins on delaying progression of chronic kidney disease: a meta-analysis].
    Liu ZR; Zhao H; Chen YR; Tang DD; Niu HX
    Nan Fang Yi Ke Da Xue Xue Bao; 2016 Apr; 36(4):445-54. PubMed ID: 27113168
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of Statin Therapy and Dose on Cardiovascular and Limb Outcomes in Peripheral Arterial Disease: A Systematic Review and Meta-analysis.
    Sofat S; Chen X; Chowdhury MM; Coughlin PA
    Eur J Vasc Endovasc Surg; 2021 Sep; 62(3):450-461. PubMed ID: 34389230
    [TBL] [Abstract][Full Text] [Related]  

  • 26. More- Versus Less-Intensive Lipid-Lowering Therapy.
    Toyota T; Morimoto T; Yamashita Y; Shiomi H; Kato T; Makiyama T; Nakagawa Y; Saito N; Shizuta S; Ono K; Kimura T
    Circ Cardiovasc Qual Outcomes; 2019 Aug; 12(8):e005460. PubMed ID: 31412729
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Impact of Chronic Kidney Disease on Risk for Vascular Events.
    Fan J; Salameh H
    Curr Vasc Pharmacol; 2016; 14(5):409-414. PubMed ID: 27456102
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of atorvastatin on renal function in patients with dyslipidemia and chronic kidney disease: assessment of clinical usefulness in CKD patients with atorvastatin (ASUCA) trial.
    Kimura G; Kasahara M; Ueshima K; Tanaka S; Yasuno S; Fujimoto A; Sato T; Imamoto M; Kosugi S; Nakao K
    Clin Exp Nephrol; 2017 Jun; 21(3):417-424. PubMed ID: 27392909
    [TBL] [Abstract][Full Text] [Related]  

  • 29. HMG CoA reductase inhibitors (statins) for dialysis patients.
    Navaneethan SD; Nigwekar SU; Perkovic V; Johnson DW; Craig JC; Strippoli GF
    Cochrane Database Syst Rev; 2009 Apr; (2):CD004289. PubMed ID: 19370598
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparative tolerability and harms of individual statins: a study-level network meta-analysis of 246 955 participants from 135 randomized, controlled trials.
    Naci H; Brugts J; Ades T
    Circ Cardiovasc Qual Outcomes; 2013 Jul; 6(4):390-9. PubMed ID: 23838105
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparative effectiveness and safety of statins as a class and of specific statins for primary prevention of cardiovascular disease: A systematic review, meta-analysis, and network meta-analysis of randomized trials with 94,283 participants.
    Yebyo HG; Aschmann HE; Kaufmann M; Puhan MA
    Am Heart J; 2019 Apr; 210():18-28. PubMed ID: 30716508
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Aspirin for primary prevention of cardiovascular disease: a meta-analysis with a particular focus on subgroups.
    Gelbenegger G; Postula M; Pecen L; Halvorsen S; Lesiak M; Schoergenhofer C; Jilma B; Hengstenberg C; Siller-Matula JM
    BMC Med; 2019 Nov; 17(1):198. PubMed ID: 31679516
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Perioperative beta-blockers for preventing surgery-related mortality and morbidity.
    Blessberger H; Kammler J; Domanovits H; Schlager O; Wildner B; Azar D; Schillinger M; Wiesbauer F; Steinwender C
    Cochrane Database Syst Rev; 2014 Sep; (9):CD004476. PubMed ID: 25233038
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of Statins on Kidney Disease Outcomes: A Systematic Review and Meta-analysis.
    Su X; Zhang L; Lv J; Wang J; Hou W; Xie X; Zhang H
    Am J Kidney Dis; 2016 Jun; 67(6):881-92. PubMed ID: 26905361
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Statins for improving renal outcomes: a meta-analysis.
    Sandhu S; Wiebe N; Fried LF; Tonelli M
    J Am Soc Nephrol; 2006 Jul; 17(7):2006-16. PubMed ID: 16762986
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Statins in chronic kidney disease: what do meta-analyses tell us?
    Upadhyay A
    Clin Exp Nephrol; 2014 Apr; 18(2):278-81. PubMed ID: 24158229
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Preoperative statin therapy for patients undergoing cardiac surgery.
    Kuhn EW; Slottosch I; Wahlers T; Liakopoulos OJ
    Cochrane Database Syst Rev; 2015 Aug; (8):CD008493. PubMed ID: 26270008
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Meta-analysis of statins in chronic kidney disease: who benefits?
    Messow CM; Isles C
    QJM; 2017 Aug; 110(8):493-500. PubMed ID: 28340216
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A meta-analysis of the role of statins on renal outcomes in patients with chronic kidney disease. Is the duration of therapy important?
    Nikolic D; Banach M; Nikfar S; Salari P; Mikhailidis DP; Toth PP; Abdollahi M; Ray KK; Pencina MJ; Malyszko J; Rysz J; Rizzo M;
    Int J Cardiol; 2013 Oct; 168(6):5437-47. PubMed ID: 24016544
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Clinical practice guidelines for the management of dyslipidemia in chronic kidney disease].
    Shoji T
    Nihon Jinzo Gakkai Shi; 2013; 55(7):1267-75. PubMed ID: 24288962
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.